Insight Molecular Diagnostics (IMDX) Debt Ratio (2017 - 2026)
Insight Molecular Diagnostics (IMDX) posted Debt Ratio of 0.0 for Q1 2026, down 76.33% sequentially from 0.02 in Q4 2025, and down 45.17% YoY from 0.01 in Q1 2025.
Insight Molecular Diagnostics (IMDX) Debt Ratio (2017 - 2026) Analysis & Trends
Insight Molecular Diagnostics has reported Debt Ratio for 12 years, with the latest figure at 0.0 in Q1 2026.
- Quarterly Debt Ratio fell 45.17% year-over-year to 0.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.0 (down 45.17% YoY) and the FY2025 annual result came in at 0.02, up 155.68% from the prior year.
- Debt Ratio retreated to 0.0 in Q1 2026 per IMDX's latest filing, from 0.02 in the prior quarter.
- Over five years, Debt Ratio peaked at 0.03 in Q4 2023 and troughed at 0.0 in Q3 2022.
- A 5-year average of 0.01 and a median of 0.01 in 2022 frame the typical range for Debt Ratio.
- The sharpest annual moves came in 2022 and 2023: Debt Ratio tumbled 95.17% in 2022, then surged 2737.24% in 2023.
- Over 5 years, Debt Ratio stood at 0.0 in 2022, then soared by 2737.24% to 0.03 in 2023, then plunged by 78.97% to 0.01 in 2024, then surged by 155.68% to 0.02 in 2025, then plunged by 76.33% to 0.0 in 2026.
- According to Business Quant data, Debt Ratio over the past three periods registered 0.0, 0.02, and 0.02 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 0.40 |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 0.30 |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 0.03 |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 0.26 |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 0.54 |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 0.24 |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 0.22 |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 0.58 |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 0.32 |
| 10 | Insight Molecular Diagnostics | 158.03 Mn | 139.50 Mn | 157,000.00 | 0.02 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.02 |
| Mar 31, 2026 | 0.00 |
| Dec 31, 2025 | 0.02 |
| Sep 30, 2025 | 0.02 |
| Jun 30, 2025 | 0.01 |
| Mar 31, 2025 | 0.01 |
| Dec 31, 2024 | 0.01 |
| Sep 30, 2024 | 0.01 |
| Dec 31, 2023 | 0.03 |
| Sep 30, 2023 | 0.00 |
| Jun 30, 2023 | 0.00 |
| Mar 31, 2023 | 0.00 |
| Dec 31, 2022 | 0.00 |
| Sep 30, 2022 | 0.00 |
| Jun 30, 2022 | 0.00 |
| Mar 31, 2022 | 0.01 |
| Dec 31, 2021 | 0.01 |
| Sep 30, 2021 | 0.01 |
| Jun 30, 2021 | 0.07 |
| Mar 31, 2021 | 0.03 |